Functional and structural analysis of two fibrinogen-activating enzymes isolated from the venoms of Crotalus durissus terrificus and Crotalus durissus collilineatus

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 1, 2009, Pages 21-29

  De Oliveira, Daniela G L ^a   Murakami, Mário T ^b   Cintra, Adelia C O ^c   Franco , João J ^c   Sampaio, Suely V ^c   Arni, Raghuvir K ^a,d  

^a INSTITUTO BUTANTAN   (Brazil)

^b LABORATÓRIO NACIONAL DE LUZ SÍNCROTRON   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d CAT CEPID   (Brazil)

Author keywords

Crotalus durissus sp; Crystallization; Functional characterization; Molecular modeling; Thrombin like enzyme

Indexed keywords

BOVINAE; CROTALUS DURISSUS; CROTALUS DURISSUS COLLILINEATUS; CROTALUS DURISSUS TERRIFICUS; VIPERIDAE;

ENZYME INHIBITOR; FIBRINOGEN; GYROXIN; SNAKE VENOM;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; CRYSTALLIZATION; ENZYME SPECIFICITY; ENZYMOLOGY; GEL CHROMATOGRAPHY; ION EXCHANGE CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY; SNAKE; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; CROTALID VENOMS; CROTALUS; CRYSTALLIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; FIBRINOGEN; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY;

EID: 64049090952     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmn003     Document Type: Article

References (38)

1. Marsh N and Williams V. Practical applications of snake venom toxins in haemostasis. Toxicon 2005, 45: 1171-1181.
2. Braud S, Bon C and Wisner A. Snake venom proteins acting on hemostasis. Biochimie 2000, 82: 851-859.
3. Kini RM. Serine proteases affecting blood coagulation and fibrinolysis from snake venoms. Pathophysiol Haemost Thromb 2005, 34: 200-204.
4. Bell WR Jr. Defibrinogenating enzymes. Drugs 1997, 54: 18-31.
5. Schafer AI. The hypercoagulable states. Ann Intern Med 1985, 102: 814-828.
6. Ernst E. Fibrinogen: its emerging role as a cardiovascular risk factor. Angiology 1994, 45: 87-93.
7. Heinrich J and Assmann G. Fibrinogen and cardiovascular risk. J Cardiovasc Risk 1995, 2: 197-205.
8. Sweetnam PM, Thomas HF, Yarnell JWG, Beswick AD, Baker IA and Elwood PC. Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease: the Caerphilly and Speedwell studies. Eur Heart J 1996, 17: 1814-1820.
9. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227: 680-685.
10. Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal Biochem 1976, 72: 248-254.
11. Ehrempreis S and Scheraga HA. Observations on analysis for thrombin and the inactivation of fibrin monomer. J Biol Chem 1957, 227: 1043-1061.
12. Rodrigues VM, Soares AM, Guerra-Sá R, Rodrigues V, Fontes MRM and Giglio JR. Structural and functional characterization of neuwiedase, a non-hemorrhagic fibrin(ogen)olytic metalloproteinase from Bothrops neuwiedi snake venom. Arch Biochem Biophys 2000, 381: 213-224.
13. Soares AM, Guerra-Sá R, Borjaoliveira CR, Rodrigues VM, Rodrigues-Simioni L, Rodrigues V and Fontes MRM, et al. Structural and functional characterization of BnSP-7, a Lys49 myotoxic phospholipase A2 homologue from Bothrops neuwiedi pauloensis venom. Arch Biochem Biophys 2000, 378: 201-209.
14. Jancarik J and Kim SH. Sparse matrix sampling-a screening method for crystallization of proteins. J Appl Crystalogr 1991, 24: 409-411.
15. Murakami MT and Arni RK. Crystallization and preliminary X-ray crystallographic studies of PROTAC, a commercial protein C activator isolated from Agkistrodon contortrix contortrix venom. Biochim Biophys Acta 2005, 1752: 202-204.
16. Murakami MT and Arni RK. Thrombomodulin-independent activation of protein C and specificity of hemostatically active snake venom serine proteinases: crystal structures of native and inhibited Agkistrodon contortrix contortrix protein C activator. J Biol Chem 2005, 280: 39309-39315.
17. Fiser A and Sali A. Modeller: generation and refinement of homologybased protein structure models. Methods Enzymol 2003, 374: 461-491.
18. Fiser A and Sali A. ModLoop: automated modeling of loops in protein structures. Bioinformatics 2003, 19: 2500-2510.
19. Eisenberg D, Luthy R and Bowie JU. VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol 1997, 277: 396-404.
20. Wiederstein M and Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 2007, 35: 407-410.
21. Willard L, Ranjan A, Zhang H, Monzavi H, Robert FB, Brian DS and David SW. VADAR: a web server for quantitative evaluation of protein structure quality. Nucleic Acids Res 2003, 31: 3316-3319.
22. Emsley P and Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004, 60: 2126-2132.
23. Markland FS. Inventory of a α- and β-fibrinogenases from snake venom. J Thromb Haemost 1991, 65: 438-443.
24. Markland FS. Snake venom fibrinogenolytic and fibrinolytic enzymes: an update inventory. J Thromb Haemost 1998, 79: 668-674.
25. Gaffney PJ, Marsh NA and Whaler BC. A coagulant enzyme from gaboon vipera venom: some aspects of its mode of action. Biochem Soc Trans 1973, 1: 1208-1209.
26. Huang QQ, Teng MK and Niu LW. Purification and characterization of two fibrinogen-clotting enzymes from five-pace snake (Agkistrodon acutus) venom. Toxicon 1983, 37: 999-1013.
27. Shieh TC, Tanaka S, Kihara H, Ohno M and Makisumi S. Purification and characterization of a coagulant enzyme from Trimeresurus flavoviridis venom. J Biochem 1985, 98: 713-721.
28. Farid TM and Tu AT. Characterization of cerastobin, a thrombin-like enzyme from the Cerastes vipera (Sahara sand iper). Biochemistry 1989, 28: 371-377.
29. Aragon-Ortiz F and Gubensek F. A thrombin-like enzyme from bushmaster (Lachesis muta stenophyrs) venom. Toxicon 1993, 31: 1435-1443.
30. Aguiar AS, Alves CR, Melgarejo A and Giovanni-de-Simone S. Purification and partial characterization of a thrombin-like/gyroxin enzyme from bushmaster (Lachesis muta rhombeata) venom. Toxicon 1996, 34: 555-565.
31. Zaganelli GL, Zaganelli MGM, Magalhães A, Diniz CR and Lima ME. Purification and characterization of a fibrinogen-clotting enzyme from the venom of jararacuçu (Bothrops jararacussu). Toxicon 1996, 34: 807-819.
32. Andrião-Escarso SH, Sampaio SV, Cunha OAB, Marangoni S, Oliveira B and Giglio JR. Isolation and characterization of a new clotting factor from Bothrops jararacussu ( jararacuçu) venom. Toxicon 1997, 35: 1043-1052.
33. Pirkle H. Thrombin-like enzymes from snake venoms: an updated inventory Scientific and Standardization Committee's Registry of Exogenous Hemostatic Factors. J Thromb Haemost 1998, 79: 675-683.
34. Viljoen CC, Meehan CM and Botes DP. Separation of Bitis gabonica (Gaboonadder) venom arginine esterases into kinin-releasing, clotting and fibrinolytic factors. Toxicon 1978, 17: 145-154.
35. Parry MA, Jacob U, Huber R, Wisner A, Bon C and Bode W. The crystal structure of the novel snake venom plasminogen activator TSV-PA: a prototype structure for snake venom serine proteinases. Structure 1998, 6: 1195-1206.
36. Harley BS and Shotton DM. Pancreatic elastase. In: Boyer PD (Ed.), The Enzymes, 1st ed. New York: Academic Press, 1971, 323-373.
37. Ouyang C, Teng TF and Huang T. Characterization of snake venom components acting on blood coagulation and platelet function. Toxicon 1992, 30: 945-966.
38. Matsui T, Fujimura Y and Titani K. Snake venom proteases affecting hemostasis and thrombosis. Biochim Biophys Acta 2000, 1477: 146-156.